Kevin R. Lind
2020 - Longboard Pharmaceuticals
In 2020, Kevin R. Lind earned a total compensation of $2.3M as President and Chief Executive Officer at Longboard Pharmaceuticals.
Compensation breakdown
| Bonus | $165,506 |
|---|---|
| Option Awards | $692,608 |
| Salary | $332,090 |
| Stock Awards | $1,087,164 |
| Other | $9,323 |
| Total | $2,286,691 |
Lind received $1.1M in stock awards, accounting for 48% of the total pay in 2020.
Lind also received $165.5K in bonus, $692.6K in option awards, $332.1K in salary and $9.3K in other compensation.
Rankings
In 2020, Kevin R. Lind's compensation ranked 4,935th out of 13,090 executives tracked by ExecPay. In other words, Lind earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,935 out of 13,090 | 62nd |
Division Manufacturing | 2,006 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 797 out of 2,254 | 65th |
Industry group Drugs | 688 out of 1,954 | 65th |
Industry Pharmaceutical Preparations | 516 out of 1,459 | 65th |
Source: SEC filing on April 13, 2022.
Lind's colleagues
We found one more compensation record of an executive who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2020.
2020
Philip Perera
Longboard Pharmaceuticals